AURKA and breast cancer: As the follow-up time of our breast cancer patient samples was not enough to analyse the clinical outcome, we explored AURKA/FOXM1 expression and prognosis in the Kaplan–Meier plotter database.29 As shown in Figure 6e, high expression of either AURKA, FOXM1 alone, or both significantly predicted poor overall survival (OS) in 1117 breast cancer patients.